Stereotactic ablative radiotherapy for the treatment of clinically localized renal cell carcinoma

Research output: Contribution to journalReview article

Abstract

Thermal ablation is currently the most studied treatment option for medically inoperable patients with clinically localized renal cell carcinoma (RCC). Recent evidence suggests that stereotactic ablative radiotherapy (SABR) may offer an effective noninvasive alternative for these patients. In this review, we explore the current literature on SABR for the primary treatment of RCC and make recommendations for future studies so that an accurate comparison between SABR and other ablative therapies may be conducted.

Original languageEnglish (US)
Article number547143
JournalJournal of Oncology
Volume2015
DOIs
StatePublished - Jan 1 2015

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Stereotactic ablative radiotherapy for the treatment of clinically localized renal cell carcinoma'. Together they form a unique fingerprint.

  • Cite this